Rivaroxaban Tablets - Won the bid for the 5th batch of national drug centralized procurement


On June 23, 2021, Jiangsu Zhongbang participated in the 5th batch of national centralized drug procurement organized by the National Organization for Centralized Drug Procurement and Use Joint Procurement Office. Our company's Rivaroxaban Tablets(10mg) was proposed to be selected in the centralized procurement.

Rivaroxaban is used to treat or prevent blood clots (venous thromboembolism, or VTE). Blood clots can occur in the legs (deep vein thrombosis, DVT) or the lungs (pulmonary embolism, PE).